Holen Sie sich die Stockscreener-App
3.695
21.05%
-0.985
Schlusskurs vom Vortag:
$4.68
Offen:
$4.05
24-Stunden-Volumen:
383.74K
Relative Volume:
1.88
Marktkapitalisierung:
$68.50M
Einnahmen:
$119.48M
Nettoeinkommen (Verlust:
$-81.65M
KGV:
-0.5429
EPS:
-6.8055
Netto-Cashflow:
$-47.13M
1W Leistung:
-15.25%
1M Leistung:
-12.02%
6M Leistung:
-69.36%
1J Leistung:
-76.73%
1-Tages-Spanne:
$3.57
$4.135
1-Wochen-Bereich:
$3.57
$4.841
52-Wochen-Spanne:
$3.00
$21.98
Outset Medical Inc Stock (OM) Company Profile
Firmenname
Outset Medical Inc
Sektor
Branche
Telefon
669-231-8200
Adresse
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
3.695 | 68.50M | 119.48M | -81.65M | -47.13M | -6.8055 |
ABT
Abbott Laboratories
|
84.32 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
285.47 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
76.15 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.93 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
79.96 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Eingeleitet | BTIG Research | Buy |
| 2024-04-05 | Hochstufung | CL King | Neutral → Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-17 | Eingeleitet | CL King | Neutral |
| 2022-11-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-07-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Eingeleitet | Cowen | Outperform |
| 2021-04-19 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-16 | Eingeleitet | Oppenheimer | Perform |
| 2020-10-12 | Eingeleitet | Barclays | Overweight |
| 2020-10-12 | Eingeleitet | BofA Securities | Buy |
| 2020-10-12 | Eingeleitet | Goldman | Buy |
| 2020-10-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Outset Medical Inc Aktie (OM) Neueste Nachrichten
Outset Medical, Inc. (OM) reports Q1 loss, lags revenue estimates - MSN
Outset Medical (OM) Q4 2025 Earnings Transcript - Yahoo Finance
Outset Medical Bets on Margin Gains and Next-Gen Tableau - TipRanks
TD Cowen Maintains Outset Medical(OM.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
Outset Medical, Inc. Q1 2026 SEC 10-Q Report – Financial Statements, Management Discussion, and Key Risks - Minichart
Q1 2026 Outset Medical Inc Earnings Call Transcript - GuruFocus
Outset Medical Q1 Earnings Call Highlights - TradingView
Earnings call transcript: Outset Medical’s Q1 2026 results show optimism with strategic focus - Investing.com
Earnings call transcript: Outset Medical’s Q1 2026 results show optimism with strategic focus By Investing.com - Investing.com South Africa
Outset Medical : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Outset Medical Inc. (OM) Misses Q1 EPS by 83c - StreetInsider
Outset Medical, Inc. 1Q 2026: Revenue $27.86M, EPS $(1.03) — 10-Q Summary - TradingView
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Outset Medical (OM) Q1 2026 Earnings Transcript - The Globe and Mail
[10-Q] Outset Medical, Inc. Quarterly Earnings Report - Stock Titan
Outset Medical (NASDAQ:OM) Falls After Q1 Revenue Miss, Despite Record Gross Margins - ChartMill
Outset Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Outset Medical (OM) Q1 2026 revenue dips 6% but margins and loss improve - Stock Titan
Outset Medical Reports First-Quarter Results - The Manila Times
Outset Medical, Inc. Reiterates Earnings Guidance for Fiscal Year 2026 - marketscreener.com
Outset Medical Reports Second Quarter 2024 Financial Results - Quantisnow
Earnings To Watch: Outset Medical Inc (OM) Reports Q1 2026 Resul - GuruFocus
Outset Medical (OM) price target decreased by 14.29% to 9.18 - MSN
Reid Health team targets manual charting reductions through Outset Medical EMR integration - Traders Union
Outset Medical (OM) to Release Quarterly Earnings on Wednesday - MarketBeat
Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026 - The Manila Times
Outset Medical Q4 2025 earnings preview - MSN
Outset Medical sets May 7 investor call with CEO, CFO - Stock Titan
Outset Medical (NASDAQ: OM) details 2026 meeting, board elections and exec pay - Stock Titan
Does Outset Medical (OM) stock justify its current price (Near Highs) 2026-04-20Insider Info - UBND thành phố Hải Phòng
AI Models Turn Cautiously More Positive on Outset Medical as Turnaround Takes Shape - TipRanks
Should investors consider Outset Medical (OM) stock right now (Technical Strength) 2026-04-18Swing Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Outset Medical, Inc. (OM) Stock Analysis: Exploring a Healthcare Play with 106.90% Potential Upside - DirectorsTalk Interviews
RBC Capital Keeps Their Hold Rating on Outset Medical (OM) - The Globe and Mail
RBC Capital Maintains Outset Medical(OM.US) With Hold Rating, Maintains Target Price $7 - Moomoo
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - GuruFocus
Outset Medical (NASDAQ:OM) Stock Rating Lowered by Wall Street Zen - MarketBeat
Outset Medical, Inc. (NASDAQ:OM) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Is Outset Medical (OM) Stock Showing Strength | Price at $4.18, Down 0.48%Community Picks - Xã Thanh Hà
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule - National Today
Outset Medical Reports Nasdaq Inducement Grant - National Today
Outset Medical (OM) EVP granted 96,000 restricted stock units in equity award - Stock Titan
Outset Medical (OM) EVP Elliott Derick A. files initial Form 3 insider report - Stock Titan
Outset Medical gives new commercial chief 96,000 stock units - Stock Titan
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Outset Medical, Inc. (NASDAQ:OM) Position Lowered by National Bank of Canada FI - 富途牛牛
TD Cowen Initiates Outset Medical(OM.US) With Buy Rating, Announces Target Price $12 - Moomoo
Outset Medical adds former Stryker leader as new EVP of commercial - MassDevice
Outset Medical names Derick Elliott commercial chief By Investing.com - Investing.com Canada
Outset Medical Names Derick Elliott as Executive Vice President of Commercial - National Today
Finanzdaten der Outset Medical Inc-Aktie (OM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Outset Medical Inc-Aktie (OM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Trigg Leslie | Chair and CEO |
Feb 17 '26 |
Sale |
3.35 |
3,361 |
11,259 |
102,342 |
| Nash Marc | EVP Operations R&D & Service |
Feb 17 '26 |
Sale |
3.35 |
1,817 |
6,087 |
39,988 |
1.25%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):